Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-05

Clinical Trial Update: Health Effects of oraL Protein Supplements in HD (The HELPS-HD Trial) [NA]

View source ↗

Summary

The HELPS-HD trial evaluating oraL Protein Supplements in patients with End-stage renal disease has completed, with results posted on 2024-11-05.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • oraL Protein Supplement

Snippet

Sponsor: Dialysis Clinic, Inc. | Conditions: End Stage Renal Disease | NA | Status: COMPLETED | Results posted: 2024-11-05